{"componentChunkName":"component---src-templates-chapter-level-1-chapter-level-1-tsx","path":"/topics/raynauds-phenomenon/references/","result":{"pageContext":{"chapter":{"id":"1b7e64ea-3359-5d63-93ff-6b661619a25e","slug":"references","fullItemName":"References","depth":1,"htmlHeader":"<!-- begin field 9b584b04-abdc-44e2-a8eb-7493fbbdd067 --><h1>References</h1><!-- end field 9b584b04-abdc-44e2-a8eb-7493fbbdd067 -->","summary":null,"htmlStringContent":"<!-- begin item 42beb3d4-9d5b-4743-b06a-cb77f00bb8a1 --><!-- begin field 3f8f2718-0e6f-443e-bf6b-22322b51308b --><ul class=\"bibliography\"><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    ABPI                </span> (<span property=\"dcterms:issued\">2017</span>) <em><span property=\"dc:title\">SPC for Adalat LA 20 mg prolonged-release tablets</span></em>. <span property=\"bibo:Collection\">Electronic Medicines Compendium</span>. <span property=\"dc:publisher\">Datapharm Communications Ltd.</span> <span rel=\"bibo:Website\"><a href=\"https://www.medicines.org.uk/emc\" target=\"_blank\" class=\"website\" data-hyperlink-id=\"89a58bcd-09b2-4164-b270-ab5e00ea5192\">https://www.medicines.org.uk/emc</a></span>            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    ABPI                </span> (<span property=\"dcterms:issued\">2019</span>) <em><span property=\"dc:title\">SPC for Coracten SR capsules 10mg or 20mg</span></em>. <span property=\"bibo:Collection\">Electronic Medicines Compendium</span>. <span property=\"dc:publisher\">Datapharm Communications Ltd.</span> <span rel=\"bibo:Website\"><a href=\"https://www.medicines.org.uk/emc\" target=\"_blank\" class=\"website\" data-hyperlink-id=\"25e55168-6e71-4c57-9aa6-ab5e00eaac83\">https://www.medicines.org.uk/emc</a></span>            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    Belch J, Carlizza A, Carpentier PH, Constans J, Khan F, Wautrecht JC                        <em>et al.</em>                </span> (<span property=\"dcterms:issued\">2017</span>) <span property=\"dc:title\">ESVM guidelines - the diagnosis and management of Raynaud&#39;s phenomenon</span>. <em>Vasa</em> <strong><span rel=\"bibo:volume\">46</span></strong>(<span rel=\"bibo:issue\">6</span>),  413-423.            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    BMJ                </span> (<span property=\"dcterms:issued\">2019</span>) <em><span property=\"dc:title\">Raynaud&#39;s phenomenon</span></em>. <span property=\"dc:publisher\">BMJ</span>. <span rel=\"bibo:Website\"><a href=\"https://bestpractice.bmj.com/topics/en-gb/193\" target=\"_blank\" class=\"website\" data-hyperlink-id=\"c95f26eb-0975-492f-81b7-ab5e00e1f386\">https://bestpractice.bmj.com/topics/en-gb/193</a></span>            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    BNF                </span> (<span property=\"dcterms:issued\">2019</span>) <em><span property=\"dc:title\">British National Formulary</span></em>. <span rel=\"bibo:Website\"><a href=\"https://bnf.nice.org.uk/\" target=\"_blank\" class=\"website\" data-hyperlink-id=\"462e4b43-e938-489f-a9a1-ab7a0099434f\">https://bnf.nice.org.uk</a></span>            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    Butendieck RR, Murray PM                </span> (<span property=\"dcterms:issued\">2014</span>) <span property=\"dc:title\">Raynaud disease</span>. <em>J Hand Surg Am</em> <strong><span rel=\"bibo:volume\">39</span></strong>(<span rel=\"bibo:issue\">1</span>),  121-124.            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    Carpentier, P.H., Satger, B., Poensin, D. and Maricq, H.R.                </span> (<span property=\"dcterms:issued\">2006</span>) <span property=\"dc:title\">Incidence and natural history of Raynaud phenomenon: a long-term follow-up (14 years) of a random sample from the general population</span>. <em>Journal of Vascular Surgery</em> <strong><span rel=\"bibo:volume\">44</span></strong>(<span rel=\"bibo:issue\">5</span>),  1023-1028. [<span rel=\"bibo:abstract\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17098538\" target=\"_blank\" class=\"abstract\" data-hyperlink-id=\"3e0d1018-98eb-47ac-9e74-ac0a0005c28f\">Abstract</a></span>]            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    Daniels J, Pauling JD, Eccleston C                </span> (<span property=\"dcterms:issued\">2018</span>) <span property=\"dc:title\">Behaviour change interventions for the management of Raynaud&#39;s phenomenon: a systematic literature review</span>. <em>BMJ Open</em> <strong><span rel=\"bibo:volume\">8</span></strong>(<span rel=\"bibo:issue\">12</span>).            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    Ennis H, Hughes M, Anderson ME, Wilkinson J, Herrick AL                </span> (<span property=\"dcterms:issued\">2016</span>) <em><span property=\"dc:title\">Calcium channel blockers for primary Raynaud&#39;s phenomenon</span></em>. <span property=\"bibo:issue\">Issue&#160;Feb 25;2:CD002069</span>. <span property=\"dc:publisher\">John Wiley &amp; Sons, Ltd.</span> <span rel=\"bibo:Website\"><a href=\"http://www.cochranelibrary.com/\" target=\"_blank\" class=\"website\" data-hyperlink-id=\"ad59f718-6953-42db-96b9-ab5e00d81588\">http://www.cochranelibrary.com</a></span>            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    Garner R, Kumari R, Lanyon P, Doherty M, Zhang W                </span> (<span property=\"dcterms:issued\">2015</span>) <span property=\"dc:title\">Prevalence, risk factors and associations of primary Raynaud&#39;s phenomenon: systematic review and meta-analysis of observational studies</span>. <em>BMJ Open</em> <strong><span rel=\"bibo:volume\">5</span></strong>(<span rel=\"bibo:issue\">3</span>).            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    Herrick AL                </span> (<span property=\"dcterms:issued\">2017</span>) <span property=\"dc:title\">Evidence-based management of Raynaud&#39;s phenomenon</span>. <em>Ther Adv Musculoskelet Dis</em> <strong><span rel=\"bibo:volume\">12</span></strong>,  317-329.            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    Hinze AM, Wigley FM                </span> (<span property=\"dcterms:issued\">2018</span>) <span property=\"dc:title\">Pharmacotherapy Options in the Management of Raynaud&#39;s Phenomenon</span>. <em>Curr Treatm Opt Rheumatol</em> <strong><span rel=\"bibo:volume\">4</span></strong>(<span rel=\"bibo:issue\">3</span>),  235-254.            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    Hirschl, M., Hirschl, K., Lenz, M.,                        <em>et al.</em>                </span> (<span property=\"dcterms:issued\">2006</span>) <span property=\"dc:title\">Transition from primary Raynaud&#39;s phenomenon to secondary Raynaud&#39;s phenomenon identified by diagnosis of an associated disease: results of ten years of prospective surveillance</span>. <em>Arthritis and Rheumatism</em> <strong><span rel=\"bibo:volume\">54</span></strong>(<span rel=\"bibo:issue\">6</span>),  1974-1981. [<span rel=\"bibo:abstract\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/16732585\" target=\"_blank\" class=\"abstract\" data-hyperlink-id=\"7033d2cd-bc14-4140-9733-ac09018502a5\">Abstract</a></span>]            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    Hughes M, Ong VH, Anderson ME, Hall F, Moinzadeh P, Griffiths B, Baildam E, Denton CP, Herrick AL                </span> (<span property=\"dcterms:issued\">2015</span>) <span property=\"dc:title\">Consensus best practice pathway of the UK Scleroderma Study Group: digital vasculopathy in systemic sclerosis</span>. <em>Rheumatology</em> <strong><span rel=\"bibo:volume\">54</span></strong>(<span rel=\"bibo:issue\">11</span>),  2015-2024.            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    Ingegnoli F, Ughi N, Crotti C, Mosca M, Tani C                </span> (<span property=\"dcterms:issued\">2017</span>) <span property=\"dc:title\">Outcomes, rates and predictors of transition of isolated Raynaud&#39;s phenomenon: a systematic review and meta-analysis</span>. <em>Swiss Med Wkly</em> <strong><span rel=\"bibo:volume\">147</span></strong>(<span rel=\"bibo:issue\">w1450</span>).            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    Khouri C, Blaise S, Carpentier P, Villier C, Cracowski JL, , Roustit M                </span> (<span property=\"dcterms:issued\">2018</span>) <span property=\"dc:title\">Drug-induced Raynaud&#39;s phenomenon: beyond β-adrenoceptor blockers</span>. <em>Br J Clin Pharmacoll</em> <strong><span rel=\"bibo:volume\">82</span></strong>(<span rel=\"bibo:issue\">1</span>),  6-16.            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    Linnemann B, Erbe M                </span> (<span property=\"dcterms:issued\">2015</span>) <span property=\"dc:title\">Raynauds phenomenon - assessment and differential diagnoses</span>. <em>Vasa</em> <strong><span rel=\"bibo:volume\">44</span></strong>(<span rel=\"bibo:issue\">3</span>),  166-167.            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    Maverakis E, Patel F, Kronenberg DG, Chung L, Fiorentino D, Allanore Y                        <em>et al.</em>                </span> (<span property=\"dcterms:issued\">2014</span>) <span property=\"dc:title\">International consensus criteria for the diagnosis of Raynaud&#39;s phenomenon</span>. <em>J Autoimmun</em> <strong><span rel=\"bibo:volume\">48-49</span></strong>,  60-65.            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    Pain CE, Constantin T, Toplak N, Moll M, Iking-Konert C, Piotto DP, Aktay Ayaz N, Nemcova D, Hoeger PH, Cutolo M, Smith V, Foeldvari I; Paediatric Rheumatology European Society (PRES) Juvenile Scleroderma Working Group.                </span> (<span property=\"dcterms:issued\">2016</span>) <span property=\"dc:title\">Raynaud&#39;s syndrome in children: systematic review and development of recommendations for assessment and monitoring</span>. <em>Clin Exp Rheumatol</em> <strong><span rel=\"bibo:volume\">Suppl 100</span></strong>(<span rel=\"bibo:issue\">5</span>),  200-206.            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    Rirash F, Tingey PC, Harding SE, Maxwell LJ, Tanjong Ghogomu E, Wells GA, Tugwell P, Pope J                </span> (<span property=\"dcterms:issued\">2017</span>) <em><span property=\"dc:title\">Calcium channel blockers for primary and secondary Raynaud&#39;s phenomenon</span></em>. <span property=\"bibo:issue\">Issue&#160;Dec 13;12:CD000467</span>. <span property=\"dc:publisher\">John Wiley &amp; Sons, Ltd.</span> <span rel=\"bibo:Website\"><a href=\"http://www.cochranelibrary.com/\" target=\"_blank\" class=\"website\" data-hyperlink-id=\"d5b4b36c-dddd-4ecf-9a0f-ab5e00dd78f6\">http://www.cochranelibrary.com</a></span>            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    Shapiro SC, Wigley FM                </span> (<span property=\"dcterms:issued\">2017</span>) <span property=\"dc:title\">Treating Raynaud phenomenon: Beyond staying warm</span>. <em>Cleve Clin J Med</em> <strong><span rel=\"bibo:volume\">84</span></strong>(<span rel=\"bibo:issue\">10</span>),  797-804.            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    Silvaab I, Teixeiraa G, Bert&#227;oc M, Almeidaa R, Mansilhad A, Vasconcelos C                </span> (<span property=\"dcterms:issued\">2016</span>) <span property=\"dc:title\">Raynaud phenomenon</span>. <em>Reviews in Vascular Medicine</em> <strong><span rel=\"bibo:volume\">4-5</span></strong>,  9-16.            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    Stringer T, Femia AN                </span> (<span property=\"dcterms:issued\">2018</span>) <span property=\"dc:title\">Raynaud&#39;s phenomenon: Current concepts</span>. <em>Clin Dermatol.</em> <strong><span rel=\"bibo:volume\">36</span></strong>(<span rel=\"bibo:issue\">4</span>),  498-507.            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    Suter, L.G., Murabito, J.M., Felson, D.T. and Fraenkel, L.                </span> (<span property=\"dcterms:issued\">2005</span>) <span property=\"dc:title\">The incidence and natural history of Raynaud&#39;s phenomenon in the community</span>. <em>Arthritis and Rheumatism</em> <strong><span rel=\"bibo:volume\">52</span></strong>(<span rel=\"bibo:issue\">4</span>),  1259-1263. [<span rel=\"bibo:abstract\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/15818710\" target=\"_blank\" class=\"abstract\" data-hyperlink-id=\"039ca9f0-a976-462d-b298-ac07015ba963\">Abstract</a></span>]            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    Thompson, A.E. and Pope, J.E.                </span> (<span property=\"dcterms:issued\">2005</span>) <span property=\"dc:title\">Calcium channel blockers for primary Raynaud&#39;s phenomenon: a meta-analysis</span>. <em>Rheumatology</em> <strong><span rel=\"bibo:volume\">44</span></strong>(<span rel=\"bibo:issue\">2</span>),  145-150. [<span rel=\"bibo:abstract\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/15546967\" target=\"_blank\" class=\"abstract\" data-hyperlink-id=\"46ba7d38-3803-48c1-a446-ac07016f1c90\">Abstract</a></span>]            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    Thompson AE, Shea B, Welch V, Fenlon D, Pope JE.                </span> (<span property=\"dcterms:issued\">2001</span>) <span property=\"dc:title\">Calcium‐channel blockers for Raynaud&#39;s phenomenon in systemic sclerosis</span>. <em>Arthritis Rheum.</em> <strong><span rel=\"bibo:volume\">44</span></strong>(<span rel=\"bibo:issue\">8</span>),  1841-1847.            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    UK Teratology Informatiion Service                </span> (<span property=\"dcterms:issued\">2016</span>) <em><span property=\"dc:title\">Use of calcium channel blockers in pregnancy</span></em>. <span rel=\"bibo:Website\"><a href=\"https://www.medicinesinpregnancy.org/bumps/monographs/USE-OF-CALCIUM-CHANNEL-BLOCKERS-IN-PREGNANCY\" target=\"_blank\" class=\"website\" data-hyperlink-id=\"c76e4357-2629-45e8-b173-ab5d00f76472\">https://www.medicinesinpregnancy.org/bumps/monographs/USE-OF-CALCIUM-CHANNEL-BLOCKERS-IN-PREGNANCY</a></span>            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    Wigley FM, Flavahan NA                </span> (<span property=\"dcterms:issued\">2016</span>) <span property=\"dc:title\">Raynaud’s Phenomenon</span>. <em>N Engl J Med.</em> <strong><span rel=\"bibo:volume\">375</span></strong>(<span rel=\"bibo:issue\">6</span>),  556-565.            </span></li></ul><!-- end field 3f8f2718-0e6f-443e-bf6b-22322b51308b --><!-- end item 42beb3d4-9d5b-4743-b06a-cb77f00bb8a1 -->","topic":{"id":"255ee7a1-48e0-54c2-a732-4e03fba17a60","topicId":"e0f3a627-69e7-4258-bfd3-06ad68e3ba94","topicName":"Raynaud's phenomenon","slug":"raynauds-phenomenon","lastRevised":"Last revised in February 2020","chapters":[{"id":"0209e319-b6f4-5f73-ae5c-6afd753453ea","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"9bb70ded-aa7a-5909-9d84-111f559bccc8","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"47c14b87-688e-5e8e-af1c-e6614c461561","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"ad9e53ac-9556-5bdd-aa04-09e22fccd689","slug":"changes","fullItemName":"Changes"},{"id":"aa95064f-a6c4-5317-a6ec-33fca3665fa5","slug":"update","fullItemName":"Update"}]},{"id":"0346daa7-fb38-5512-b2c8-7f0d5d4b7c91","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"074b9165-8cc3-56b5-a9fa-483516a026aa","slug":"goals","fullItemName":"Goals"},{"id":"dadcf48d-9a98-54cf-baab-c0b65179b8f1","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"d272b294-ed60-5488-8640-d756cbe670a3","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"9dcdeaed-4201-583c-a5a9-5dcb4ead9acb","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"4c107602-0bb8-52d9-b277-5639494a105e","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"72ac11d0-1027-5c50-ae82-9ae1e1bf92b7","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"0559a1bc-62df-54ef-846b-db71b06fbe87","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"2ec7ca08-f644-50e8-b54e-c6378c7053b0","slug":"definition","fullItemName":"Definition"},{"id":"951db58c-3bcb-56ef-be5f-1e0fd9fdbd81","slug":"causes-of-or-diseases-associated-with-raynauds-phenomenon","fullItemName":"Causes of, or diseases associated with Raynaud's phenomenon:"},{"id":"b9b9e063-b592-5419-8f15-8f350c8de255","slug":"prevalence-incidence","fullItemName":"Prevalence and incidence"},{"id":"16789ea7-d3e6-5c24-a51f-e9f57845b88b","slug":"prognosis","fullItemName":"Prognosis"},{"id":"b914d639-5ff2-526f-86e9-1280331ece9b","slug":"complications","fullItemName":"Complications"}]},{"id":"1478d9b3-2ba3-5103-9fab-2a67d58f88f4","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"509776f6-588e-5896-9432-bf45ef2f63e1","slug":"clinical-features","fullItemName":"Clinical features"},{"id":"9a10980a-a167-52bd-9991-be6f6cd68c50","slug":"assessment","fullItemName":"Assessment"},{"id":"ab1aab22-cf2f-584c-b073-a5bba7ae4c6d","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"143745f3-74bd-57da-b042-3dd311837d98","fullItemName":"Management","slug":"management","subChapters":[{"id":"f6006983-20db-5702-8a8c-9763d45ab3cf","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"ede08fed-d06c-5c6c-9c34-9ada648e6c09","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"1c7cb268-2a82-5737-b0ee-332487a61ea1","slug":"nifedipine","fullItemName":"Nifedipine"}]},{"id":"f6403106-c5ec-5705-bdcf-a225c5de60f9","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"8a93fc9c-f20c-58a4-a5db-33420cd3b27a","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"e2a1391d-6c3d-5d36-b072-abc59f16980c","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"bfa3b4f4-feec-59d7-9574-f36fc1bcf5cd","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"18ed7dfb-e0e7-5be9-9a57-0ab24f1666c5","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"2bf5741c-d447-5f96-8155-861976265e79","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"52d565ac-2dac-556a-9bc8-c5c8946df2ed","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"1b7e64ea-3359-5d63-93ff-6b661619a25e","fullItemName":"References","slug":"references","subChapters":[]}]},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}